A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

NCT06662383 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Retatrutide
DRUG: Tirzepatide

Sponsor

Eli Lilly and Company